macrophages produce HERV-K102, which stimulates
innate immunity, HERV-K HML2 expression correlates
of conventional therapies needs to consider cancer-specific and patient-specific programming of
innate immunityAsadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC,
immune checkpoint
microarchitectures, we analyzed the relationship of the material under study with the
immune system cells. Particular